Clinical trial

Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets

NCT01510522

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2012-06-01

PhasePHASE4

Study timeline

Study start (unknown)2012-06-01Date precision: month

Registry last updated2014-02-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus Type 2unresolved

Interventions

GlucophageDRUG · verified · RxNorm: Glucophage

Sponsors & collaborators

Merck KGaA, Darmstadt, Germanylead sponsor

Merck, S.L., Spaincollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01510522 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.